Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients
Clinical trial NCT03866577 · TERMINATED
Trial details
- NCT number
- NCT03866577
- Sponsor
- Momenta Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2021-06-09
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.